Clinical Trials

A Prospective Clinical Study of Phenylketonuria (PKU)

A Study of PTC923 in Participants With Phenylketonuria

A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks

Amino Acid Kinetics of GMP-AA in Healthy Human Volunteers

Antioxidant Signature in Adult Patients With Phenylketonuria

Baby Detect : Genomic Newborn Screening

Effect of Kuvan on Neurocognitive Function, Blood Phenylalanine Level, Safety, and Pharmacokinetics in Children With PKU

Efficacy and Safety of Orally Administered Engineered Probiotics (CBT102-A) for the Treatment of Children With Phenylketonuria

Efficacy and Safety of SYNB1618 and SYNB1934 in Adult Patients With Phenylketonuria

Evaluation of Phe Fluctuation in PKU Pts Treated With PKU GOLIKE Versus Standard Amino Acid Protein Substitute.

Evaluation of PKU Sphere Liquid

Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy

Impact of Single Exercise Session Conducted Prior to PKU Type Meal on Appetite Hormones and Energy Intake

Kuvan® in Phenylketonuria Patients Less Than 4 Years Old

Low Phenylalanine Diet for Mothers With Phenylketonuria (PKU)

Nutrition Status of Adults Treated With Pegvaliase

Nutrition Status of Adults With PKU Before and During Treatment With Pegvaliase

Nutritional and Neurotransmitter Changes in PKU Subjects on BH4

Phase 2 Study of Glycomacropeptide Versus Amino Acid Diet for Management of Phenylketonuria

Phenylalanine and Its Impact on Cognition